France Pharmaceuticals & Healthcare Report Q3 2018
France’s pharmaceutical and healthcare spending will remain on a positive growth trajectory over a multi-year horizon,creating renewed opportunities for drugmakers and healthcare service providers. Rising demand for healthcare due to an ageingpopulation will underpin this trend. That said, the need to create savings will translate into government cost-control measures,including targeting drug spending as a means to keep costs in line with spending growth targets. Meanwhile, labour marketreform and government incentives for innovation will improve the investment environment in several sectors, including biomedicalindustries, slowly reversing the loss of competitiveness of recent years.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook